V companies categorized / 12331
Abcuro
| id | 12331 |
|---|---|
| name | Abcuro |
| category_id | 9 |
| sector_or_kind | Biotech / Pharma |
| sector_slug | biotech_pharma |
| parent_category_id | 1 |
| parent_kind | Operating Company |
| parent_kind_slug | operating_company |
| classification_tier | — |
| classification_confidence | — |
| hq_city | — |
| hq_country | US |
| description | Abcuro raised $66M in Series D funding to advance ulviprubart in an inclusion body myositis trial. NEA participated in the round alongsid... |
| tenant_id | 1 |